ロード中...
A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer
BACKGROUND: Bone-targeted agents are usually administered to breast cancer patients with bone metastases every 3–4 weeks. Less frequent (‘de-escalated’) treatment may provide similar benefits with improved safety and reduced cost. METHODS: To systematically review randomised trials comparing de-esca...
保存先:
| 出版年: | J Bone Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4723383/ https://ncbi.nlm.nih.gov/pubmed/26909282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbo.2013.05.001 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|